Science Explorer Back to mapMap
Discussion
Researcher · Innate Pharma (France) · France

Yannis Morel

Yannis Morel publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, CAR-T cell therapy research and Immunotherapy and Immune Responses.

OpenAlex
World rank
#443,594
of 7,710,434 ranked researchers
Rank in France
#23,673
of 324,115
Works
103
Citations
6.2k
Citations per work
59.9
h-index
23
i10-index 36Top 25% in Immunology
Yannis Morel

What does Yannis Morel research?

Yannis Morel's work is mostly in Immunology and Microbiology (36%), Medicine (24%), Biochemistry, Genetics and Molecular Biology (12%).

Life Sciences: 50 works · 48.3% of their workImmunology and Microbiology: 37 works · 35.8% of their workImmunology: 37 works · 35.8% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 12.5% of their workMolecular Biology: 13 works · 12.5% of their workEverything else: 28 works · 27.6% of their workHealth Sciences: 25 works · 24.1% of their workMedicine: 25 works · 24.1% of their workOncology: 15 works · 14.2% of their workEndocrinology, Diabetes and Metabolism: 5 works · 4.7% of their workInfectious Diseases: 3 works · 2.6% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 2.6% of their workTHEIR WORKYannis Morel103works
Life Sciences48%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology3735.8%
    2. Biochemistry, Genetics and Molecular Biology1312.5%
  2. Everything else2827.6%
    1. Medicine2524.1%
  1. 1Immunology36% of their works
  2. 2Oncology14% of their works
  3. 3Molecular Biology12% of their works
  4. 4Endocrinology, Diabetes and Metabolism5% of their works
  5. 5Radiology, Nuclear Medicine and Imaging3% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe Yannis Morel's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Autoimmunity, Inflammation and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. NK Cell Recognition341 topic
  2. Natural Killer Cells341 topic
  3. Cancer Immunotherapy322 topics
  4. CAR T Cells201 topic
  5. Chimeric Antigen Receptor201 topic
  6. Autoimmunity182 topics
  7. Inflammation152 topics
  8. Dendritic Cells121 topic
  9. Foxp3121 topic
  10. Immunity121 topic
  11. TGF-ß121 topic
  12. Pattern Recognition Receptors91 topic
  13. Toll-like Receptors91 topic
  14. Immune Checkpoint Blockade71 topic
  15. PD-1 and PD-L171 topic
  16. Congenital Adrenal Hyperplasia61 topic
  17. Galectins61 topic
  18. Immune Regulation61 topic
  19. Steroid 21-Hydroxylase Deficiency61 topic

Where does Yannis Morel work?

Yannis Morel's main affiliation in the publication record is Innate Pharma (France), France.

How many publications and citations does Yannis Morel have?

OpenAlex counts 103 works and 6,167 citations for Yannis Morel, an h-index of 23, ranking #443,594 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yannis Morel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.